Sarepta Therapeutics (SRPT) said a third patient has died from acute liver failure after receiving one of its gene therapies, intensifying scrutiny over the safety of its treatments, Bloomberg ...

UnitedHealth stock is deeply oversold, undervalued, and primed for a recovery. Read why analysts forecast UNH to have a ~29% ...

On Thursday, Microsoft (NASDAQ:MSFT)-backed OpenAI launched an AI agent for its chatbot ChatGPT. The company said ChatGPT can ...

The Federal Trade Commission set aside orders barring Hess CEO John Hess from joining Chevron's board and former Pioneer ...

CLOs have been one of the best-performing income asset classes of these past few years. Explore the full comparison of CLOZ ...

SoFi Technologies shows strong growth, expanding margins, and potential for $1B in earnings by FY '27, pointing to a major ...

Permian Resources delivers high margins, strong FCF, and low valuation through disciplined operations in the Delaware Basin.

President Donald Trump has authorized the Justice Department to seek the release of grand jury testimony related to the ...

Teledyne (TDY) stock shines in digital imaging, drones, and defense, but stock potential seems priced in. Explore diversified ...

Pharvaris' innovative approach to treating hereditary angioedema (HAE) with deucrictibant. Read here for an investment ...

Having passed the midpoint of the year, several of our key economic predictions for 2025 are on track, including weaker US ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...